Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Neuroscience Discovery

Beyond Traditional Therapeutics: How Digital Therapeutics Reshape Neurological and Neuropsychiatric Treatments

Two case studies show how digital therapeutics can potentially treat neurological and neuropsychiatric conditions, areas where conventional therapeutics have encountered obstacles.
Read More
Neuroscience Discovery

University of Pennsylvania and FAST to Develop AAV Gene Therapy for Angelman Syndrome

The collaboration hopes to develop a AAV gene therapy for rare genetic disease Angelman syndrome.
Read More
Neuroscience Discovery

Neural Stem Cell Workflow Solutions

Read More
Neuroscience Discovery

Challenges in Developing Organoids for Neuroscience

Oxford Global’s panel discussion: Translational Models from 3D to Animal Model of Disease – Neuroscience, asked experts to share their experience of developing organoids for translational neuroscience.
Read More
Neuroscience Discovery

Prothena and Evotec Score Major Deals with Bristol Myers Squibb for Neuroscience Breakthroughs

Prothena will receive $55 million to license its clinical Alzheimer's drug candidate, while Evotec will receive $40 million for its late-stage clinical programs.
Read More
Neuroscience Discovery

Investigating Target Identification and Validation Modelling in Neurodegenerative Disease

The significance of reproducibility, fidelity, and translatability in models, as well as the importance of using multiple models to cross-validate therapeutic targets.
Read More
Neuroscience Discovery

Nasal Spray Shows Remarkable Efficacy in Easing Social Anxiety: Vistagen's Fasedienol Promises New Hope

Positive phase III results propel innovative pherine nasal spray as potential game-changer for millions struggling with social anxiety disorder. Vistagen's novel mechanism of action sparks optimism after previous setback.
Read More
Neuroscience Discovery

Interview with Nicolas Vachicouras, CEO, Neurosoft Bioelectronics: Subdural Brain Interfaces

Talking with Nicolas Vachicouras, CEO of Neurosoft Bioelectronics about their subdural brain interface and its inaugural clinical testing for recording the human brain in the context of an epilepsy resective surgery.
Read More
Neuroscience Discovery

Interview with Valentina Mosienko, Fellow and Lecturer in Neuroscience, University of Bristol

Navigating the neuroscientific pathways for anxiety towards druggable targets.
Read More
Neuroscience Discovery

Gene Discovered to Drive Anxiety Could Prove an Effective Drug Target

The discovery could be a game-changer for the many people that suffer from anxiety related mental health disorders.
Read More
Neuroscience Discovery

Positive Results Achieved from Phase III Trial of MDMA-Assisted Therapy

Significant findings after the Schedule I controlled drug completes Phase III clinical trial for PTSD patients.
Read More
Neuroscience Discovery

Discovery of Fentanyl Vaccine Called “Game Changer” with Some Sceptical

The antibody-based vaccine has been successful in rat models but has had critics who would rather see a focus on harm reduction.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery